2026 NPPES data Pharmacotherapy Pharmacist NPI 1467820720 PHARM.D.
Verify on CMS →

PETE FOWLER, PHARM.D.

Pharmacotherapy Pharmacist in LIVERMORE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 1K beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: PETE FOWLER, PHARM.D. is a Pharmacotherapy Pharmacist ([object Object]) practicing in LIVERMORE, California with a Medicare Part D prescribing footprint of 2K claims across 1K beneficiaries — 100% brand-name prescribing .

What stands out: PETE FOWLER, PHARM.D. filed 1,933 Medicare Part D claims in 2023 across LIVERMORE, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

PETE FOWLER, PHARM.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 09/03/2015

NPI 1467820720

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

1,933 387% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in California

How Pharmacotherapy Pharmacist compares to other specialties among California providers

California providers

Pharmacotherapy Pharmacist share within California

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PETE FOWLER, PHARM.D. is a Pharmacotherapy Pharmacist provider practicing in LIVERMORE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D.. NPI: 1467820720. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PETE FOWLER, PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D. credentials at 300 PULLMAN ST, LIVERMORE, CA, 94551, with a listed phone of (818) 624-0148. NPI 1467820720 was issued on 09/03/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FOWLER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,933 prescription claims written by this provider, covering 1,256 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

300 PULLMAN ST
LIVERMORE, CA 94551

Provider Details

NPI 1467820720
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D.
Gender Male
NPI Issued 09/03/2015

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to PETE FOWLER, PHARM.D.. To verify PETE FOWLER, PHARM.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

PETE FOWLER, PHARM.D. — brand share 100.0%
Specialty average (est.)

100% brand-name claims vs 0% generic, on 1,933 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,933
Total Claims
$1.2M
Total Drug Cost
1,256
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,723
Total Day Supply
171,736
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
76.8 years
Avg HCC Risk Score
2.09
Gender Split
46% female / 54% male
Age Distribution
<65: 34, 65-74: 462, 75-84: 552, 85+: 208

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pradaxa
Dabigatran Etexilate Mesylate
1,429
Eliquis
Apixaban
367
Xarelto
Rivaroxaban
137

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How PETE FOWLER, PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

PETE FOWLER, PHARM.D.'s 1,933 claims are above the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FOWLER.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is PETE FOWLER, PHARM.D.'s specialty?
PETE FOWLER, PHARM.D. specializes in Pharmacotherapy Pharmacist and practices in LIVERMORE, California. Credentials: PHARM.D..
How much does PETE FOWLER, PHARM.D. prescribe under Medicare Part D?
In 2023, PETE FOWLER, PHARM.D. wrote 1,933 Medicare Part D claims totaling $1.2M in drug costs for 1,256 beneficiaries.
Where is PETE FOWLER, PHARM.D. located?
PETE FOWLER, PHARM.D. is located at 300 PULLMAN ST, LIVERMORE, CA, 94551. Phone: (818) 624-0148.
What is PETE FOWLER, PHARM.D.'s NPI number?
PETE FOWLER, PHARM.D.'s National Provider Identifier (NPI) is 1467820720, issued on 09/03/2015.
Does PETE FOWLER, PHARM.D. prescribe more brand-name or generic drugs?
PETE FOWLER, PHARM.D.'s prescribing is 100% brand-name and 0% generic drugs by claim count, with $1.2M in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does PETE FOWLER, PHARM.D. prescribe most often?
Based on 2023 Medicare Part D data, PETE FOWLER, PHARM.D.'s most frequently prescribed drugs include Pradaxa, Eliquis, Xarelto. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PETE FOWLER, PHARM.D. accept Medicare?
PETE FOWLER, PHARM.D. appears in CMS Medicare data with 1,933 Part D claims and 1,256 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PETE FOWLER, PHARM.D.'s credentials?
PETE FOWLER, PHARM.D.'s NPI is 1467820720 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology